Lista de obras - M.T. Armentero - Dominio Público Uruguay

A reliable indirect cell-labelling protocol for optical imaging allows ex vivo visualisation of mesenchymal stem cells after transplantation

artículo científico publicado en 2013

A role for brain cyclooxygenase-2 and prostaglandin-E2 in migraine: effects of nitroglycerin

scientific article published on 01 January 2007

Activation of brain metabolism and fos during limbic seizures: the role of locus coeruleus.

artículo científico publicado en 2008

Activation of the CREB/c-Fos Pathway during Long-Term Synaptic Plasticity in the Cerebellum Granular Layer

artículo científico publicado en 2017

Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease

artículo científico publicado en 2011

Animal models of Parkinson's disease

artículo científico publicado en 2012

Behavioral responses and Fos activation following painful stimuli in a rodent model of Parkinson's disease

artículo científico publicado en 2007

Bioenergetic and proteolytic defects in fibroblasts from patients with sporadic Parkinson's disease.

artículo científico publicado en 2014

Calcium homeostasis is dysregulated in parkinsonian patients with L-DOPA-induced dyskinesias.

artículo científico publicado en 2009

Correction: Search for Cellular Stress Biomarkers in Lymphocytes from Patients with Multiple Sclerosis: A Pilot Study.

artículo científico publicado en 2012

Dietary restriction does not prevent nigrostriatal degeneration in the 6-hydroxydopamine model of Parkinson's disease

artículo científico publicado en 2008

Dopamine receptor agonists for Parkinson's disease.

artículo científico

Dopamine receptor agonists mediate neuroprotection in malonate-induced striatal lesion in the rat.

artículo científico publicado en 2002

Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates L-DOPA-induced rotational behavior in a rodent model of Parkinson's disease

artículo científico publicado en 2015

Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease

artículo científico publicado en 2010

Effects of homocysteine on apoptosis-related proteins and anti-oxidant systems in isolated human lymphocytes

artículo científico publicado en 2004

Epstein-Barr virus-dependent lymphoproliferative disease: critical role of IL-6.

artículo científico publicado en 2000

Genetically engineered animal models of Parkinson's disease: From worm to rodent

scientific article published on 27 December 2018

Human adult tonsil xenotransplantation into SCID mice for studying human immune responses and B cell lymphomagenesis

artículo científico publicado en 2000

Impaired hepatic function and central dopaminergic denervation in a rodent model of Parkinson's disease: A self-perpetuating crosstalk?

artículo científico publicado en 2011

Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease

artículo científico publicado en 2017

Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.

artículo científico publicado en 2015

L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: biochemical and behavioral studies

artículo científico publicado en 2014

L-DOPA-treatment in primates disrupts the expression of A(2A) adenosine-CB(1) cannabinoid-D(2) dopamine receptor heteromers in the caudate nucleus

artículo científico publicado en 2013

Labeling and tracking of human mesenchymal stem cells using near-infrared technology

artículo científico publicado en 2013

Long-term culture and differentiation of CNS precursors derived from anterior human neural rosettes following exposure to ventralizing factors

artículo científico publicado en 2010

Modifications of neuroactive steroid levels in an experimental model of nigrostriatal degeneration: potential relevance to the pathophysiology of Parkinson's disease

artículo científico publicado en 2011

Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease.

artículo científico publicado en 2009

Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease

artículo científico publicado en 2004

Neuroprotective effects mediated by dopamine receptor agonists against malonate-induced lesion in the rat striatum ⬇️

artículo científico publicado el 1 de octubre de 2003

Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine: implications for reparative therapy in Parkinson's disease

scientific article published on 01 March 2012

Neuroprotective potential of adenosine A2A and cannabinoid CB1 receptor antagonists in an animal model of Parkinson disease.

artículo científico publicado en 2014

New pharmacological avenues for the treatment of L-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors

artículo científico publicado en 2012

Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson's disease

artículo científico publicado en 2012

Oxidative stress and pro-apoptotic conditions in a rodent model of Wilson's disease.

artículo científico publicado en 2005

Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.

artículo científico publicado en 2011

Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease.

artículo científico publicado en 2010

Peripheral inflammation and neuroprotection: systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease

artículo científico publicado en 2006

Peripheral-Central Neuroimmune Crosstalk in Parkinson's Disease: What Do Patients and Animal Models Tell Us?

scholarly article by Marie Therese Fuzzati-Armentero et al published 2019 in Frontiers in Neurology

Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease

artículo científico publicado en 2005

Proteasomal inhibition and apoptosis regulatory changes in human isolated lymphocytes: the synergistic role of dopamine

artículo científico publicado en 2008

Role of central dopaminergic circuitry in pain processing and nitroglycerin-induced hyperalgesia

artículo científico publicado en 2008

Search for cellular stress biomarkers in lymphocytes from patients with multiple sclerosis: a pilot study

artículo científico publicado en 2012

Selective blockade of mGlu5 metabotropic glutamate receptors is protective against hepatic mitochondrial dysfunction in 6-OHDA lesioned Parkinsonian rats.

artículo científico publicado en 2015

Selective lesion of the substantia nigra pars reticulata reduces the cortical Fos expression induced by stimulation of striatal D1-like receptors, in the rat.

artículo científico publicado en 2006

Single or combined treatment with L-DOPA and quinpirole differentially modulate expression and phosphorylation of key regulatory kinases in neuroblastoma cells

artículo científico publicado en 2013

Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease

artículo científico publicado en 2007

The 6-hydroxydopamine model: news from the past

scientific article published on 02 July 2008

Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model

artículo científico publicado en 2007

Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat.

artículo científico publicado en 2009

Unilateral lesion of the subthalamic nucleus enhances cortical fos expression associated with focally evoked seizures in the rat.

artículo científico publicado en 2006

hu-PBL-SCID mice: an in vivo model of Epstein-Barr virus-dependent lymphoproliferative disease

artículo científico publicado el 1 de enero de 1998

Lista de obras de M.T. Armentero

A reliable indirect cell-labelling protocol for optical imaging allows ex vivo visualisation of mesenchymal stem cells after transplantation

A role for brain cyclooxygenase-2 and prostaglandin-E2 in migraine: effects of nitroglycerin

Activation of brain metabolism and fos during limbic seizures: the role of locus coeruleus.

Activation of the CREB/c-Fos Pathway during Long-Term Synaptic Plasticity in the Cerebellum Granular Layer

Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease

Animal models of Parkinson's disease

Behavioral responses and Fos activation following painful stimuli in a rodent model of Parkinson's disease

Bioenergetic and proteolytic defects in fibroblasts from patients with sporadic Parkinson's disease.

Calcium homeostasis is dysregulated in parkinsonian patients with L-DOPA-induced dyskinesias.

Correction: Search for Cellular Stress Biomarkers in Lymphocytes from Patients with Multiple Sclerosis: A Pilot Study.

Dietary restriction does not prevent nigrostriatal degeneration in the 6-hydroxydopamine model of Parkinson's disease

Dopamine receptor agonists for Parkinson's disease.

Dopamine receptor agonists mediate neuroprotection in malonate-induced striatal lesion in the rat.

Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates L-DOPA-induced rotational behavior in a rodent model of Parkinson's disease

Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease

Effects of homocysteine on apoptosis-related proteins and anti-oxidant systems in isolated human lymphocytes

Epstein-Barr virus-dependent lymphoproliferative disease: critical role of IL-6.

Genetically engineered animal models of Parkinson's disease: From worm to rodent

Human adult tonsil xenotransplantation into SCID mice for studying human immune responses and B cell lymphomagenesis

Impaired hepatic function and central dopaminergic denervation in a rodent model of Parkinson's disease: A self-perpetuating crosstalk?

Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease

Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.

L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: biochemical and behavioral studies

L-DOPA-treatment in primates disrupts the expression of A(2A) adenosine-CB(1) cannabinoid-D(2) dopamine receptor heteromers in the caudate nucleus

Labeling and tracking of human mesenchymal stem cells using near-infrared technology

Long-term culture and differentiation of CNS precursors derived from anterior human neural rosettes following exposure to ventralizing factors

Modifications of neuroactive steroid levels in an experimental model of nigrostriatal degeneration: potential relevance to the pathophysiology of Parkinson's disease

Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease.

Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease

Neuroprotective effects mediated by dopamine receptor agonists against malonate-induced lesion in the rat striatum ⬇️

Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine: implications for reparative therapy in Parkinson's disease

Neuroprotective potential of adenosine A2A and cannabinoid CB1 receptor antagonists in an animal model of Parkinson disease.

New pharmacological avenues for the treatment of L-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors

Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson's disease

Oxidative stress and pro-apoptotic conditions in a rodent model of Wilson's disease.

Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.

Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease.

Peripheral inflammation and neuroprotection: systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease

Peripheral-Central Neuroimmune Crosstalk in Parkinson's Disease: What Do Patients and Animal Models Tell Us?

Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease

Proteasomal inhibition and apoptosis regulatory changes in human isolated lymphocytes: the synergistic role of dopamine

Role of central dopaminergic circuitry in pain processing and nitroglycerin-induced hyperalgesia

Search for cellular stress biomarkers in lymphocytes from patients with multiple sclerosis: a pilot study

Selective blockade of mGlu5 metabotropic glutamate receptors is protective against hepatic mitochondrial dysfunction in 6-OHDA lesioned Parkinsonian rats.

Selective lesion of the substantia nigra pars reticulata reduces the cortical Fos expression induced by stimulation of striatal D1-like receptors, in the rat.

Single or combined treatment with L-DOPA and quinpirole differentially modulate expression and phosphorylation of key regulatory kinases in neuroblastoma cells

Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease

The 6-hydroxydopamine model: news from the past

Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model

Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat.

Unilateral lesion of the subthalamic nucleus enhances cortical fos expression associated with focally evoked seizures in the rat.

hu-PBL-SCID mice: an in vivo model of Epstein-Barr virus-dependent lymphoproliferative disease